Suppr超能文献

药物纳米混悬剂:传统与创新药物制剂之间的 ZIP 工具。

Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.

机构信息

a 1 University of Torino, Department of Drug Science and Technology , Via Pietro Giuria 9, 10125, Torino, Italy.

b 2 Department of Applied Science and Technology, Politecnico di Torino , Corso Duca degli Abruzzi 24, 10129 Torino, Italy.

出版信息

Expert Opin Drug Deliv. 2015;12(10):1607-25. doi: 10.1517/17425247.2015.1043886. Epub 2015 May 10.

Abstract

INTRODUCTION

A nanosuspension or nanocrystal suspension is a versatile formulation combining conventional and innovative features. It comprises 100% pure drug nanoparticles with sizes in the nano-scale range, generally stabilized by surfactants or polymers. Nanosuspensions are usually obtained in liquid media with bottom-up and top-down methods or by their combination. They have been designed to enhance the solubility, the dissolution rate and the bioavailability of drugs via various administration routes. Due to their small sizes, nanosuspensions can be also considered a drug delivery nanotechnology for the preparation of nanomedicine products.

AREAS COVERED

This review focuses on the state of the art of the nanocrystal-based formulation. It describes theory characteristics, design parameters, preparation methods, stability issues, as well as specific in vivo applications. Innovative strategies proposed to obtain nanomedicine formulation using nanocrystals are also reported.

EXPERT OPINION

Many drug nanodelivery systems have been developed to increase the bioavailability of drugs and to decrease adverse side effects, but few can be industrially manufactured. Nanocrystals can close this gap by combining traditional and innovative drug formulations. Indeed, they can be used in many pharmaceutical dosage forms as such, or developed as new nano-scaled products. Engineered surface nanocrystals have recently been proposed as a dual strategy for stability enhancement and targeting delivery of nanocrystals.

摘要

简介

纳米混悬剂或纳米晶体混悬剂是一种结合了传统和创新特点的多功能制剂。它由 100%纯药物纳米颗粒组成,粒径处于纳米级范围,通常通过表面活性剂或聚合物稳定。纳米混悬剂通常通过自下而上和自上而下的方法或其组合在液体介质中获得。它们旨在通过各种给药途径提高药物的溶解度、溶解速率和生物利用度。由于其粒径较小,纳米混悬剂也可以被视为用于制备纳米药物产品的药物传递纳米技术。

涵盖领域

本综述重点介绍基于纳米晶体的制剂的最新技术状态。它描述了理论特性、设计参数、制备方法、稳定性问题以及特定的体内应用。还报告了用于获得纳米药物制剂的创新性策略。

专家意见

已经开发了许多药物纳米递药系统来提高药物的生物利用度并降低不良反应,但很少有系统可以工业化生产。纳米晶体可以通过结合传统和创新的药物制剂来弥补这一差距。事实上,它们可以原样用于许多药物剂型,也可以开发为新型纳米级产品。最近提出了工程表面纳米晶体作为增强纳米晶体稳定性和靶向递送的双重策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验